2
Tetrahedron
of all synthesized compounds were confirmed by their spectral
6c
18.7
>80
28.5
15
>80
20.5
>80
10
33
>80
30
7.8
>80
8.0
>80
>80
>80
11
data.
7a
7
b
Cisplatin
10
20.8
a
b
c
From the data shown in Table 1, compound 6c with 6-(N-
phenyl)thiosemicarbazone group and 7b with 6-(5'-
methylamino)thiadiazole ring show a better selective cytotoxicity
on A-549 cells with IC50 value of 7.8 and 8.0µM, and are almost
inactive on HEK293T cells. Both compounds display a better
antiproliferative activities than a positive control cisplatin
(20.8µM), and deserve further study.
HO
HO
O
HO
CHO
OH CHO
1
2
3
d
e
S
S
HO
N
N
R
N
R
O
CHO
O
N
H
N
N
N
H
H
H
4
5
H
H
6
: a R = H; b R = CH3; c R = Ph
3 3 2 2 3
Reagents and conditions: a: O /(CH ) S; b: Al O /Ph; c: Jones reagent; d:
o
Acknowledgments
NH
2
NHCSNH
2
, 80 C; e: NH
2
OH.HCl/AcONa.
Scheme 1
The authors acknowledge the financial support of the
National Natural Science Foundation of China (No: 21462009),
the Natural Science Foundation of Guangxi Province (No:
2014GXNSFAA118052) and the Guangxi Colleges and
University Key Laboratory Foundation of Beibu Gulf Oil and
Natural Gas Resource Effective Utilization (No: 2016KLOG10).
Last, Beckman rearrangement of hydroxyimino group of
compound 6a-6b in SOCl /THF gave A-homo-lactame ring.
2
During the process of the reaction, 6-thiosemicarbazone group
was converted to thiadiazole ring to obtain target products 7a-7b.
In the H NMR of 7a, the chemical shift of C
1
7
-H at 2.89 ppm
appears as a dd-peak with a coupling constant of 17.7 and 4.5
ppm which illustrate that the C7-H and C8-H are located on an
anti-form position of a-bond. This result shows that the
stereochemistry of C-7 is the β-configuration. On the other side,
compound 6c couldn’t be transformed into compound 7c because
there is a larger benzene ring in the structure of its 6-substituted
group
Conflict of Interest
The authors declare no conflict of interest.
References and notes
1
2
.
.
Bansal R.; Acharya P. C. Chem. Rev., 2014, 114 (14), 6986.
Chunfang G.; Haibin S.; Binbin Q.; Lei Y.; Dandan Z.; Yanmin H.;
Jianguo C. Chin. J. Org. Chem., 2014, 34, 1730. (in Chinese)
Singh H.; Kapoor V. K.; Paul D. Heterosteroids and drug research. In:
Progress in Medicinal Chemistry, Vol. 16; Ellis GP, West GB. Eds.;
Springer: Amsterdam, 1979, pp 35–150.
HN
H
3
.
S
O
N
NHR
a
N
S
7a: R = H; 7b: R = CH3
HO
N
N
R
4.
Huang Y. M.; Cui J. G.; Gan C, F.; Yao Q. C.; Jia L. Y. Progress in
Chem., 2012, 24(1), 61. (in Chinese).
N
N
H
H
H
6a-6c
No Product
c: R = Ph
5
.
Venetia K.; Eleftheria M.; Zafiroula I.; Dionysios M.; Manolis F.; Anna
K.; Evaggelia A.; Sotiris N. Mutation Research, 2003, 535, 79.
Dimitrios T. P. T. Cancer Lett., 2006, 243, 202.
Natalija M. K.; Mira S. B.; Željko Ž.; Mirjana D. P.; Zorica D. J.;
Vladimir D. P. Steroids, 2007, 72, 406.
7
6
7
.
.
2
Reagents and conditions: a: SOCl /THF.
Scheme 1
8
9
.
.
Anna I. K.; Manolis A. F.; Evagelia S. A.; Athanasios P.; George N. P.;
Sotiris S. N. Bioorg. Med. Chem., 2008, 16, 5207.
Dimitrios T. P. T.; George D. G.; Catherine K.; Athanasios P.;
Panayiotis K.; Charalambos C. Breast Can. Res. Treat., 2006, 97, 17.
The cytotoxic activity of compounds 4-7 was determined in
vitro on HeLa (human cervical carcinoma), CNE-2
nasopharyngeal carcinoma), HEPG2 (human liver carcinoma),
A-549 (human lung carcinoma) cancer cell lines and HEK293T
Normal Kidney Epithelial Cells) cell lines. The MTT method
(
10. Dimitrios T.; Elena G.; Panagiotis D.; Nikolaos N.; Vasiliki S. Steroids,
016, 115, 1.
2
1
1
1
1
1
1. Huang Y. M.; Cui J. G.; Zhong Z. G.; Gan C. F.; Zhang W. Y.; Song H.
C. Bioorg. Med. Chem. Lett. 2011, 21, 3641.
2. Huang Y. M.; Cui J. G.; Chen S. J.; Gan C. F.; Zhou A. M. Steroids,
(
was used to analyze the antiproliferative activity. The results are
summarized as IC50 values in µmol/L in Table 1.
2
011, 76, 1346.
3. Huang Y. M.; Chen S. J.; Cui J. G.; Gan C. F.; Liu Z. P.; Wei Y. L.;
Song H. C. Steroids, 2011, 76, 690.
4. Huang Y. M.; Cui J. G.; Chen S. J.; Gan C. F.; Yao Q. C.; Lin Q. F.
Bioorg. Med. Chem. Lett., 2013, 23, 2265.
5. Cui J. G.; Lin Q. F.; Gan C. F.; Yao Q. C.; Su W.; Huang Y. M.
Steroids, 2014, 79, 14.
Table 1. Antiproliferative activity of compounds 4-7 (IC50 in µM)(MTT
method)
Comp.
HeLa
>80
>80
>80
>80
>80
>80
CNE-2
>80
HEPG2
>80
A-549
>80
>80
>80
>80
>80
>80
HEK293T
>80
4
5
5
a
>80
>80
>80
16. Huang Y. M.; Cui J. G.; Zeng Q. X.; Zeng C.; Chen Q.; Zhou A. M.
Steroids, 2012, 77, 829.
17. Huang Y. M.; Cui J. G.; Chen S. J.; Lin Q. f.; Song H. C.; Gan C. F.; Su
B.; Zhou A. M. Mar. Drugs, 2014, 12, 1715.
b
>80
>80
>80
5
6
c
>80
>80
>80
a
16.5
>80
>80
>80
6
b
>80
>80